VR Logo

Hikal Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1988

Chairman: Jai Hiremath

Managing Director: Jai Hiremath

Group: Kalyani

Listing: NSE: HIKAL, BSE: 524735

Headquarters: Mumbai, Maharashtra

Website: www.hikal.com

Key Facts

Market cap: R 2,113.99 Cr

Revenue (TTM): R 1,507.74 Cr

Earnings (TTM): R 94.78 Cr

Cash: R 63.57 Cr

Total Debt: R 644.72 Cr

Promoters' ownership: 68.77%

Liquidity: High

52 Week range: R 56.90 - 204.55

Face value: R2.00

Shares outstanding: 12,33,00,750

10 Years Aggregate:

  • CFO: 1,520.59 Cr
  • EBITDA: 2,048.57 Cr
  • Net Profit: 586.26 Cr

Stock Performance

Time Period Hikal S&P BSE Healthcare S&P BSE Small Cap
YTD4.040.933.57
1 month2.271.905.48
3 months0.3510.6825.83
1 Year31.9556.2227.93
3 Years4.5113.72-1.23
5 Years12.547.2612.68
10 Years14.1812.827.72
As on 20-Jan-2021
Year Hikal S&P BSE Small Cap S&P BSE Healthcare
202041.4532.1161.45
2019-26.92-6.85-3.55
20180.05-23.41-5.89
20179.4459.640.49
201627.161.77-12.88
201510.096.7615.06
201464.7669.2447.43